
Dental Biomaterials Market Report 2026
Global Outlook – By Type (Metallic Biomaterials, Ceramic Biomaterials, Polymeric Biomaterials, Metal-Ceramic Biomaterials, Natural Biomaterials, Composites Biomaterials), By Bone Graft Material Type (Allograft, Xenograft, Synthetic), By Application (Orthodontics, Implantology, Prosthodontics, Other Applications), By End-User (Dental Hospitals And Clinics, Dental Laboratories, Dental Academies And Research Institutes, Dental Product Manufacturers) – Market Size, Trends, Strategies, and Forecast to 2035
Dental Biomaterials Market Overview
• Dental Biomaterials market size has reached to $9.01 billion in 2025 • Expected to grow to $13.42 billion in 2030 at a compound annual growth rate (CAGR) of 8.2% • Growth Driver: The Surging Demand For Dental Biomaterials In The Face Of Rising Prevalence Of Dental Disorders • Market Trend: Trend In Growth Factor-Rich Biomaterials For Optimal Tissue Regeneration • North America was the largest region in 2025.What Is Covered Under Dental Biomaterials Market?
Dental biomaterials are substances used in dentistry to restore, replace, or enhance the function of damaged or missing teeth and oral tissues. These materials are designed to interact with biological systems and can be classified into several categories based on their application and properties. The main types of dental biomaterials are metallic biomaterials, ceramic biomaterials, polymeric biomaterials, metal-ceramic biomaterials, natural biomaterials and composite biomaterials. Metallic biomaterials, which are frequently utilized in joint replacements, dental implants, orthopedic fixations, and stents, are created to offer internal support to biological tissues. The various bone graft material types are allograft, xenograft, and synthetic. The application includes orthodontics, implantology, prosthodontics, and others, which are used in dental hospitals and clinics, dental laboratories, dental academies, research institutes and dental product manufacturers.
What Is The Dental Biomaterials Market Size and Share 2026?
The dental biomaterials market size has grown strongly in recent years. It will grow from $9.01 billion in 2025 to $9.79 billion in 2026 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to increasing prevalence of dental disorders, expansion of restorative dental procedures, growth in cosmetic dentistry demand, rising adoption of implant-based treatments, availability of advanced dental materials.What Is The Dental Biomaterials Market Growth Forecast?
The dental biomaterials market size is expected to see strong growth in the next few years. It will grow to $13.42 billion in 2030 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to increasing focus on aesthetic dental outcomes, rising adoption of digital dentistry workflows, growing demand for minimally invasive procedures, expansion of dental tourism, advancements in biomaterial engineering. Major trends in the forecast period include increasing adoption of zirconia and ceramic materials, rising demand for biocompatible dental solutions, growing use of cad/cam compatible biomaterials, expansion of composite and hybrid biomaterial usage, enhanced focus on long-term oral compatibility.Global Dental Biomaterials Market Segmentation
1) By Type: Metallic Biomaterials, Ceramic Biomaterials, Polymeric Biomaterials, Metal-Ceramic Biomaterials, Natural Biomaterials, Composites Biomaterials 2) By Bone Graft Material Type: Allograft, Xenograft, Synthetic 3) By Application: Orthodontics, Implantology, Prosthodontics, Other Applications 4) By End-User: Dental Hospitals And Clinics, Dental Laboratories, Dental Academies And Research Institutes, Dental Product Manufacturers Subsegments: 1) By Metallic Biomaterials: Stainless Steel, Titanium Alloys, Cobalt-Chromium Alloys 2) By Ceramic Biomaterials: Alumina, Zirconia, Calcium Phosphate Ceramics 3) By Polymeric Biomaterials: Polyethylene, Polymethyl Methacrylate (PMMA), Polyurethane 4) By Metal-Ceramic Biomaterials: Porcelain-Fused-To-Metal (PFM), Metal-Ceramic Composites 5) By Natural Biomaterials: Collagen, Chitosan, Hydroxyapatite 6) By Composites Biomaterials: Resin Composites, Glass Ionomer CompositesWhat Is The Driver Of The Dental Biomaterials Market?
The rising prevalence of dental disorders is expected to propel the growth of the dental biomaterials market going forward. Dental disorders are conditions that harm the oral cavity. The rising prevalence of dental disorders is primarily due to poor oral hygiene practices, which allow plaque buildup and increase the risk of cavities and gum disease. Dental biomaterials are helpful in providing effective solutions for dental disorders by providing added protection, remineralization, and bioactive prevention of dental issues. For instance, in March 2025, according to the Office for Health Improvement and Disparities, a UK-based government department, in the 2023 to 2024 period, 5-year-old schoolchildren residing in the most deprived fifth of the country were more than twice as likely to have experienced dentinal decay (32.2%) compared to those in the least deprived fifth (13.6%). Therefore, the rising prevalence of dental disorders drives the dental biomaterials industry.Key Players In The Global Dental Biomaterials Market
Major companies operating in the dental biomaterials market are Straumann Group, Geistlich Biomaterials, Zimmer Biomet Holdings Inc., Dentsply Sirona Inc., 3M Company, Koninklijke DSM N.V., Kuraray Co Ltd., Henry Schein Inc., Mitsui Chemicals Inc., Ivoclar Vivadent AG, Bego Medical GmbH, Institut Straumann AG, BioHorizons IPH Inc., Nobel Biocare Services AG, ACE Surgical Supply Company Inc., Biomatlante, Align Technology Inc., Carestream Dental LLC, Datum Dental Ltd., VITA Zahnfabrik H Rauter Gr KG, Coltene Whaledent AG, DMG Chemisch-Pharmazeutische Fabrik GmbH, Heraeus Kulzer GmbH, Kavo Dental GmbH, Septodont Holding, Ultradent Products Inc., VOCO GmbHGlobal Dental Biomaterials Market Trends and Insights
Major companies operating in the dental biomaterials market are developing new products, such as the growth factor-rich membrane, to meet larger customer bases and increase revenue. A growth factor-rich membrane is a biomaterial containing a concentrated blend of growth factors, cytokines, and other biological enhancers designed to promote optimal tissue regeneration and wound healing. For instance, in October 2023, ZimVie, a US-based medical instrument manufacturing company, launched the Biotivity A/C Plus Membrane, a growth factor-rich biomaterial. This innovative membrane, derived from human placental tissue, stands out in the market for its unique approach to dental procedures. With a composition of growth factors, cytokines, chemokines, and hyaluronic acid, it promotes optimal wound healing during jaw repair and reconstruction for dental implants. Notably, the Biotivity A/C Plus Membrane undergoes minimal manipulation, preserving natural properties, and is sterilized using the Excellion Process. Its antibiotic-free processing distinguishes it from other A/C membranes on the market.What Are Latest Mergers And Acquisitions In The Dental Biomaterials Market?
In April 2023, Henry Schein Inc., a US-based provider of health care solutions to office-based dental and medical practitioners, acquired Biotech Dental S.A.S. for an undisclosed amount. With this acquisition, establish a digital workflow that offers customers a seamless experience, boosting case acceptance and enhancing clinical outcomes for practitioners. Biotech Dental S.A.S is a French-based manufacturer of dental biomaterials.Regional Outlook
North America was the largest region in the dental biomaterials market share in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, SpainWhat Defines the Dental Biomaterials Market?
The dental biomaterials market consists of sales of dental cement, membranes, and soft tissue regeneration products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.Dental Biomaterials Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $9.79 billion |
| Revenue Forecast In 2035 | $13.42 billion |
| Growth Rate | CAGR of 8.6% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Type, Bone Graft Material Type, Application, End-User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Straumann Group, Geistlich Biomaterials, Zimmer Biomet Holdings Inc., Dentsply Sirona Inc., 3M Company, Koninklijke DSM N.V., Kuraray Co Ltd., Henry Schein Inc., Mitsui Chemicals Inc., Ivoclar Vivadent AG, Bego Medical GmbH, Institut Straumann AG, BioHorizons IPH Inc., Nobel Biocare Services AG, ACE Surgical Supply Company Inc., Biomatlante, Align Technology Inc., Carestream Dental LLC, Datum Dental Ltd., VITA Zahnfabrik H Rauter Gr KG, Coltene Whaledent AG, DMG Chemisch-Pharmazeutische Fabrik GmbH, Heraeus Kulzer GmbH, Kavo Dental GmbH, Septodont Holding, Ultradent Products Inc., VOCO GmbH |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
